
Federal prosecutors have charged numerous New York pharmacy owners and employees with criminal violations relating to OTC card exchanges and nominal benefits. Because these practices are widespread, providers should act immediately to limit their exposure as the crackdown expands.
Government’s Healthcare Fraud Investigation
At the time of this update, the federal government has filed criminal charges against numerous pharmacy owners and employees for violations of the Anti-Kickback Statute and Healthcare Fraud relating to OTC card exchanges and nominal benefits, including $3 supermarket coupons, $2 in-store credits, and waivers of $3 copayments.
The government alleges in these cases that patients, pharmacies, and physicians all participated in a loop of bribery, referrals and billing fraud. These charges are severe and carry prison terms of up to 10 years’ incarceration.
Healthcare Fraud Based on OTC Benefits
Specifically, the government alleges that patients were paid kickbacks by pharmacies in the form of OTC and other common benefits, such as co-pay waivers.
The pharmacies then allegedly referred their patients to physicians, who wrote medically unnecessary prescriptions for high-reimbursing drugs and DME. The patients, in turn, returned to the referring pharmacies, where the prescriptions were filled to the tune of tens of millions of dollars in federal reimbursement.
Although the government has yet to unveil charges against physicians who participated in the scheme, those charges have either been filed under seal and the physicians are cooperating, or they will be filed publicly soon.
Healthcare Fraud Theory of Prosecution
Notably, the theory of prosecution in these cases is incredibly broad. For example, the government alleges that “a common means of providing kickbacks and bribes to Medicare beneficiaries and Medicaid recipients and facilitating fraud schemes for medically unnecessary medications is to fail to charge such individuals the copayments due for their prescriptions.”
On the other hand, the OIG has recognized that copay waivers may be appropriate based on individualized assessments of financial need, and has never charged a patient with receiving a so-called bribe in the form of a co-pay waiver.
Accordingly, the sweeping charging theory in these cases means that a pharmacist may be criminally charged if he or she has waived copays or offered other nominal benefits to customers, such as accepting OTC cards for non-eligible items, who then filled medically unnecessary prescriptions, irrespective of whether the pharmacist knew the order lacked medical necessity.
This exposure is troubling for a number of reasons. First, pharmacists typically have no insight whatsoever into whether a prescribed drug is medically necessary to treat a patient’s condition. Second, the circumstances in which a pharmacist can legally refuse to fill a prescription vary, and may depend on state law. Third, despite the prevalence of co-pay waivers and OTC violations throughout the industry, federal prosecutors are using data to target “outlier” pharmacies without regard to customer base or underlying patient conditions.
HLA Specializes in Healthcare Fraud Defense
In short, if your pharmacy has offered nominal benefits involving OTC cards and co-pay waivers to customers, you may have criminal exposure. There are a number of immediate steps that clients can take to better understand and limit that risk. At Health Law Alliance, our experienced healthcare defense attorneys have represented numerous clients under federal investigation for the practices described in this article. Our firm’s mission is simple: use unmatched experience and insight to defend our clients against insurance conglomerates, the federal government, and state agencies. We used to work for them. Now let us fight for you. Contact us today for a COMPLIMENTARY consultation. We can help.
MORE ARTICLES BY CATEGORY
Guidance for New Entrants on Navigating PBM Audit Complexities
New pharmacy owners face complex PBM audit requirements that demand strict documentation, accurate claims, and ongoing compliance. Establishing strong recordkeeping systems and proactive audit readiness can help prevent costly recoupments and protect long-term network participation.
Read More >>How Pharmacies Can Challenge Unfair PBM Audit Findings
PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.
Read More >>Top Red Flags That May Trigger a PBM Audit
PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.
Read More >>Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week
Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.
Read More >>